About us
Committed to becoming the world's leading R&D enterprise of innovative single domain antibody drugs

Shanghai Novamab Biopharmaceuticals Co., Ltd., located in Zhoupu International Medical Park, Pudong New Area, Shanghai, is a clinical stage biopharmaceutical company dedicated to the development of innovative sdAb drugs.

With a solid foundation in sdAb research and development for more than 10 years, Novamab has established the first and only sdAb development platform covering the full biopharmaceutical process in China. The philosophy of Novamab is "to build itself into a global leading Bio-Tech enterprise focusing on respiratory and autoimmune diseases, aiming to bring safer, more effective and more convenient therapeutic drugs to the patients all over the world.

single domain antibody
Research and Development
Full-process single domain antibody development platform
Our products

At present, Novamab has several sdAb drugs in multiple  pipelines, covering respiratory disease, autoimmune disease, Immuno-Oncology and other conditions. And Novamab has established strategic partnerships with many well-known enterprises at home and abroad.ips with many well-known enterprises at home aic partnerships with many well-known enterprises at home and abroad.